Biomedical subjects
Publications and source records attributed to H Bier.
The average time the test feed remains in sheep was determined with ewes during three stages of the reproduction cycle. The feed was labelled with 51Cr2O3. Experiment conditions are described under which the experiments can be carried out within the permissible limits.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The effects of intralesional chemotherapy with 7 different drugs on line 10 hepatoma grown in strain 2 guinea pigs were compared with the sensitivity of line 10 tumor cells in vitro, using a micro modification of the tumor stem assay with capillary tubes. A modified method was used to evaluate the in vitro dose-response curves. The correlation for in vivo/in vitro resistance was found to be 100% and for in vivo/in sensitivity it was 80%.
The present study deals with the influence of intratumoral injections of BCG cell-wall preparations (CWP) on the development of malignant tumors in the head-neck region. Line 10 tumor cells in strain 2 guinea pigs were used in a first assay. It became evident that intratumoral BCG-CWP injection leads to total tumor regression, a situation which can also be achieved by radical surgery. In contrast to the radically operated animals, those injected intratumorally with BCG-CWP develop a tumor-specific immunity. A second animal system was used to examine the effect of intratumoral BCG-CWP treatment on the development of autochthonous squamous cell carcinomas in cows. In this model, radical surgery leads to a clinical cure in all cases, while intratumoral BCG-CWP therapy leads to a complete clinical cure in 50% of the animals (observation period: 1 year). On the basis of experiments performed with animals systems, a clinical study was initiated to examine the effect of preoperative BCG-CWP injection in patients with squamous cell carcinomas in the head-neck region. At present, the case study involves 24 patients. The cumulative percentage of patients in complete tumor remission is now 69% for BCG-CWP pretreated tumor patients and 39% for patients who underwent surgery only. The hitherto existing life-table analyses of both therapy groups and the small degree of side effects resulting from BCG-CWP seem to justify a continuation of the study until a statistically confirmed statement can be made about the curative effect of BCG-CWP within the framework of a combination therapy in patients with squamous cell carcinomas in the head-neck region.
Explore the source record for details and available documents.
The intense clinical interest in bleomycin as an anti-tumour agent has led to different methods of administration in an attempt to administer sufficiently high concentrations of the drug to the tumor. Therefore, a study was designed to determine the distribution and the therapeutic effect of a bleomycin emulsion and aqueous bleomycin after different routes of application. The tissue distribution of radioactively labelled bleomycin emulsion and aqueous bleomycin was determined in tumor-free CF 1 and tumor-bearing (EL 4, L 1210) C 57 Bl 6 and DBA 2 mice after local (s.c., i.t.) and systemic (i.v.) injection. The distribution studies for aqueous 57Co-bleomycin showed increased activity in the injection sites and the lymph nodes draining the injection sites after s.c. and i.t. injection compared to i.v. administration of the drug. In comparison to the aqueous local administration, the application of 57Co-bleomycin emulsion resulted in a disproportional increase of the 57Co-bleomycin concentration at the injection sites and in the draining lymph nodes. To prove the therapeutic relevance of the bleomycin tissue distribution tumor-bearing (line 10) strain 2 guinea pigs were treated with different modes of bleomycin. Animals with already lymphogenously metastasized tumors have been cured by means of low i.t. doses of the bleomycin emulsion. Guinea pigs treated with i.t. administration of aqueous bleomycin need, compared to the bleomycin emulsion, five times higher doses for tumor-free survival. Intravenously treated animals died either because of progressive tumor growth or because of toxic bleomycin effects. These findings made by animal experiments favor the i.t. treatment of head and neck carcinomas with a bleomycin emulsion.
The antigen relationship which exists between luteinising hormone of various animal species, on the one hand, and human luteinising hormone as well as human chorionic gonadotrophin, on the other, was the background against which possible approaches were tested to the preparation of a heterologous in-vitro test for serum LH determination in cattle and sheep. The following conclusions may be drawn from the results so far obtained: --A homologous or heterologous test with specific relevance to the determination of human LH, on the basis of hLH-anti-hLH or hLH-anti-hCG is not suitable for the determination of LH in animal serum (cattle, sheep). --Quantitative and specific measurement of LH concentrations in the blood of cattle (sheep) is possible by means of an ovine-LH-anti-ovine/bovine-LH (or anti-bovine-LH) test system which is based on cross-reactivity between luteinising hormones of cattle and sheep. --Differentiated measurement of various LH concentrations in animal serum will be possible under certain specific assay conditions, with ovine LH as tracer, ovine or bovine LH as standard, and hCG antiserum. Yet, the clinical value of that heterologous radio-immuno-assay method is attributable primarily to its potential to measure peak values within the cycle to determine the time of ovulation rather than to the built-in possibility to determine base values of the cycle.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.